at www.tipranks.com (Tue, 10-Nov 9:01 AM)
Piper Sandler Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)
at www.tipranks.com (Tue, 10-Nov 7:56 AM)
Arrowhead spotlights pancreatitis-risk drop and up to 65% LDL-C reduction at AHA 2026
Market Chameleon (Mon, 9-Nov 9:56 AM)
Arrowhead reports lower pancreatitis rates, early cholesterol drug results
at seekingalpha.com (Sun, 8-Nov 12:19 PM)
Earnings Week Ahead: CSCO, CRWV, PLUG, ALC, AMAT, ACB, RKLB, ASTS, and more
at seekingalpha.com (Sun, 8-Nov 8:07 AM)
Novartis is said to be abandoning Ionis heart drug after late-stage trial setback
at seekingalpha.com (Sat, 7-Nov 11:36 AM)
ARWR Highlights ARO-MAPT’s 73% Mean Tau Reduction at Day 105, Pointing to Potential Quarterly Dosing
Market Chameleon (Wed, 14-Oct 8:11 AM)
